Coast Independent Review Board Ranks 2356 on the Inc. 5000 List
Inc. magazine ranked Coast Independent Review Board No. 2356 on its 27th annual Inc. 5000 list of the fastest-growing private companies in the U.S.
Inc. Magazine Announces Its 27th Annual List of America’s 5000 Fastest-Growing Private Companies
Colorado Springs, Colo. August 28, 2008– Inc. magazine ranked Coast Independent Review Board No. 2356 on its 27th annual Inc. 5000 list of the fastest-growing private companies in the U.S.
As an Inc. 5000 honoree, Coast Independent Review is now a member of the most influential business clubs in America. The company you keep is notable, as Inc. 5000 alumni include Bill gates of Microsoft, Larry Ellison of Oracle, and many more. The Inc. 5000 is ranked according to percentage revenue growth from 2004 through 2007.
Coast Independent Review Board (IRB) safeguards the rights and well-being of clinical research trial participants for Phase I-IV pharmaceutical, medical device and repository trials. Coast IRB’s associates focus on the customer. “We continue to look for new ways to keep our customer relationships central to our process,” states Darren McDaniel Founder & Managing Director. Additionally, McDaniel promotes educational opportunities to help improve the standards in the industry. This month Coast IRB sponsored a contest to test the ethical savvy of clinical associates. Coast will continue to renovate progress with in the industry by promoting ethical reforms. As part of its continual quest for improvement, Coast IRB is in the process of achieving accreditation with the Association for the Accreditation of Human Research Protection Program (AAHRPP) which ensures high-quality human research protection programs in order to promote excellent, ethically sound research.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
